Skip to main content

Table 3 Clinical outcomes according to group

From: The importance of intravenous immunoglobulin treatment in critically ill patients with necrotizing soft tissue infection: a retrospective cohort study

 

Non-IVIG (n = 26)

IVIG (n = 22)

Clinical outcomes

 In-hospital death

8/26 (30.8%)

5/22 (22.7%)

 ICU length of stay (d)

11.5 (3–19)

11 (6–21)

 Development of acute renal failure

13/26 (50%)

18/22 (81.8%)

 Development of ARDS

6/26 (23.1%)

5/22 (22.7%)

 Development of septic shock

12/26 (46.2%)

17/22 (77.3%)

  1. Data expressed as numbers and percentage (%) or median and (interquartile range, IQR). ICU, intensive care unit; ARDS, acute respiratory distress syndrome; IVIG, intravenous immunoglobulins